The human parathyroid hormone receptor (hPTH1R), containing a nine-amino acid sequence of rhodopsin at its C-terminus, was transiently expressed in COS-7 cells and solubilized with 0.25% n-dodecyl maltoside. Approximately 18 µg of hPTH1R were purified to homogeneity per mg of crude membranes by single-step affinity chromatography using 1D4, a monoclonal antibody to a rhodopsin epitope. The Nterminus of the hPTH1R is Y23, consistent with removal of the 22 amino-acid signal peptide. Comparisons of hPTH1R by quantitative immunoblotting and Scatchard analysis revealed that 75% of the receptors in membrane preparations were functional; there was little, if any, loss of functional receptors during purification. The binding affinity of the purified hPTH1R was slightly lower than membrane-embedded hPTH1R (Kd=16.5+/-1.3 vs 11.9+/-1.9 nM) and the purified receptors bound rat [Nle 8, 21 , Y 34 ] PTH (1-34)-NH 2 [PTH (1-34)], and rat [I 5 ,W 23 ,Y 36 ] PTHrP (5-36)-NH 2 with indistinguishable affinity. Maximal displacement of 125 I-PTH (1-34) binding by rat [α−amino isobutylic acid (
Characterization of Purified, Functional PTH1Receptors 7 encoding the epitope (TETSQVAPA) recognized by 1D4, was inserted in-frame immediately upstream of the stop codon at the 3'-end of the hPTH1R sequence. The modified hPTH1R cDNA was subcloned at BamH1 and XbaI sites in a pcDNA3 expression vector (Invitrogen, Carlsbad, CA). The accuracy of the modified receptor construct was confirmed by sequencing the entire receptor (Tuft University, Department of Physiology, Sequencing Core Facility, Boston, MA).
Transient transfection of COS-7 cell. All plasmid DNAs were prepared using the EndoFree plasmid Maxi kit (Qiagen Inc., Valencia, CA) and stored at -20˚C in sterile buffer containing 10mM Tris-HCl and 1mM EDTA (pH 7.5). Transfection of COS-7 cells with purified plasmid containing the modified hPTH1R cDNA was performed using FuGene 6 transfection reagents. In brief, 10 µg of DNA in l ml of DMEM were mixed with 30 µl of FuGene 6 for 20 min at 21˚C and the mixture was added to 60-75% confluent COS-7 cells in a 15-cm dish. Cells were harvested after 72 h for preparation of membranes. For studies of hPTH1R on intact cells, COS-7 cells were grown in 24-well plates and transfected with 250 ng of cDNA and 0.75 µl of FuGene 6 per well. Cells were studied 72 h after transfection.
Preparation of the membrane fraction from COS-7 cells. Confluent monolayers of
COS-7 cells, grown in 15 cm dishes, were washed with PBS and harvested by scraping with a Teflon policeman in 5 ml of Buffer A (10 mM Tris-HCl and 4 mM EDTA, pH 7.4), containing proteinase inhibitors (10 µg/ml pepstatin, 2 µg/ml aprotinin, 10 µg/ml chymostatin and 10 µg/ml leupeptin) (Sigma, St. Louis, MO). Then, cell lysates were homogenized by 30 strokes with a Duall tissue grinder (Kontes, Vineland, NJ). The homogenates were centrifuged at 700 x g (Beckman J2-21 centrifuge, JLA rotor, Beckman Instruments, Berkeley, CA) for 10 min at 4˚C to remove nuclei and debris.
Supernatants were centrifuged at 40,000 x g for 30 min at 4˚C, the supernatants were by guest on http://www.jbc.org/ Downloaded from Characterization of Purified, Functional PTH1Receptors 8 aspirated, and the membrane-enriched pellets were suspended in Buffer B (50 mM Tris-HCl, 0.15M NaCl, 2 mM CaCl 2 , 5 mM KCl, 5mM MgCl 2 , 4 mM EDTA, 20% glycerol, pH 7.5) with the same proteinase inhibitors at a protein concentration of 2 mg/ml, and stored at -80˚C. Receptors in these crude membrane preparations were stable for at least one month under these conditions. Solubilization and purification of hPTH1R. The membrane proteins were diluted to a concentration of 1 mg/ml with Buffer B, and then were solubilized by incubation with an equal volume of 0.5% DM in Buffer B (45 min, 4˚C). A small amount of insoluble material was separated from the clear supernatant by ultracentrifugation at 100,000 x g for 30 min at 4˚C (Beckman L8-55M, 70.1 TI rotor, Beckman Instrument, Berkeley, CA).
The supernatant, diluted 2-fold with Buffer B, was added to 1 ml of Sepharose 4B to which 1D4 had been coupled using CNBr, and was placed on a rocker platform for 1.5 h at 4˚C. The solution and resin then were transferred to Bio-Rad Econo column (0.7x5 cm, Bio-Rad, Hercules, CA), the resin was washed with 50 ml of Buffer B containing 0.05% DM, and the hPTH1R was eluted by competition with the 9 amino-acid rhodopsin peptide (100 µM, 2 ml of Buffer B containing 0.05% DM).
Quantification of the hPTH1R. Affinity-purified hPTH1R was concentrated approximately 25-fold on Microcon YM-50 filters (Millipore Co., Bedford, MA) by centrifugation at 12,000 x g for 40 min, and hydrolyzed for 24 h at 110 0 C in 6N HCl containing 0.05% β-mercaptoethanol. The hydrolysate was vacuum dried, re-dissolved in a citrate buffer, and amino acid analysis was performed on a Beckman System 6300 analyzer. Quantification was made after correction for the 9 amino-acid rhodopsin epitope. The same preparation was then used to develop a standard to rapidly assess receptor concentration and recovery by Western blotting. Purified hPTH1R (1.9 µg) was dissolved in 250 µl of buffer B containing 5 mg/ml of bovine serum albumin (BSA) and by guest on http://www.jbc.org/ Downloaded from Characterization of Purified, Functional PTH1Receptors 9 serially diluted over a range of 1:25 (1.5 ng) to 1:3200 (11.8 pg) in the same buffer.
Standards were established by "slot-blotting" 5µl of each dilution onto nitrocellulose membranes (Bio-Dot SF apparatus, Bio-Rad, Hercules, CA) and stored for future use.
Samples of solubilized crude membrane and purified hPTH1R at several dilutions in Buffer B containing 0.05% DM were then applied to the nitrocellulose membranes. The membranes were blocked by treatment with PBS containing 5% dry milk and 0.2% Tween-20, and then were incubated with 1D4 antibody for 1 h at room temperature (RT).
A HRP conjugated anti-mouse IgG (1:10,000) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) then was added and membranes were developed using Western Lightning Cheminoluminescence Reagent Plus (Perkin Elmer Life Sciences, Inc., Boston, MA).
The concentration of hPTH1R was determined by interpolation from the intensities of the serially diluted standard. Radioreceptor assay. PTH (1-34) was labeled with 125 I using chloramine T as catalyst, and purified by HPLC as described previously (25, 83) . Monoiodinated 125 I-PTH(1-34) (2,000 Ci/mmol) was used within 3 weeks of labeling. Radioreceptor assays with intact COS-7 cells that express the hPTH1R were conducted as described previously (1, 25) . To Separation of bound from free radioligand was achieved by applying samples to 25 mm PVDF filters (0.45 µm, Millipore Co., Bedford, MA), which had been pre-soaked with Buffer B containing 10% FBS before mounting them on a 12-port vacuum manifold (Millipore Co., Bedford, MA). Filters were washed with 3 ml of chilled buffer B (x2), transferred to tubes, and radioactivity counted with a gamma counter.
The affinity of purified hPTH1R also was assessed after elution from the affinity support. Ninety-six well plates pre-coated with protein G by the manufacture (Pierce, Rockford, IL) were reacted with a 1:10 dilution of G48 (100 µl, 16 h, 4°C) that had been immunodepleted of antibodies that recognize the epitope in the hPTH1R N-terminal ectodomain. The wells were then washed with 100 µl of Buffer B (x2), and unreacted sites on the wells were blocked by incubation with Buffer B, which contained 3% heatinactivated BSA (100 µl, 1 h, RT). After washing the wells with Buffer B (100 µl, x2), a solution containing purified hPTH1R was added in 50 µl of Buffer B containing 0.05%
DM. After 1-h incubation at RT, unlabeled PTH (1-34) at various concentrations (5 µl)
and 125 I-PTH (1-34) (7-10 x 10 4 cpm, 50 µl) were added in Buffer B containing 20% FBS and 0.05% DM and incubated for an additional hour. The contents of each well were aspirated, the wells were washed with Buffer B (100 µl, x2), and bound radioactivity was recovered by incubation with 1N NaOH (100 µl, 30 min, at RT). The contents of each well were transferred to a glass tube and the radioactivity was counted.
Measurement of intracellular cAMP and inositol phosphate (IP) accumulation.
Intracellular cAMP and IP were measured as described previously (19, 25) .
Preparation of membrane fraction from Sf9 cells. Recombinant
Gαs-, β1and γ2subunits were generated in Sf9 cells and purified by minor modifications of previously described methods (84) . The concentration of each G-protein subunit was estimated by Coomassie blue staining using BSA as standard. Purified G-protein subunits were stored in aliquots (10-50 ng/µl) at -80˚C. Co., Danbury, CT). The sonicated solution was repeatedly passed (x20) through a polycarbonate membrane (100 nm, pore size) mounted on Liposo Fast-Basic extrusion device (Avestin Inc., Ottawa, Canada). The purified, concentrated hPTH1R (7.6 pmol in gently to a polyethylene tube containing a discontinuous sucrose gradient (10, 20, 30 , and 50%; 400 µl, 400 µl, 400 µl, and 300 µl, respectively). The tubes were centrifuged in SW-60 rotor at 160,000 x g for 16 h at 4°C and incorporation of hPTH1R into phospholipid vesicles was assessed. Samples (120-170 µl) were collected by puncturing the bottom of the tube with a 21-gauge needle. Aliquots from each fraction were counted for [ 3 H], and hPTH1R was assessed by immunoblotting with 1D4 antibody. 
Reconstitution of hPTH1R in phospholipid vesicles

Incorporation of GTPγS into Gs after reconstitution with hPTH1R and G protein
Results and Discussion
Characterization of the modified hPTH1R. COS-7 cells were transiently transfected with either wild-type hPTH1R or hPTH1R, which had been modified by substitution of five corresponding amino-acids from the rat PTH1R sequence encoded by exon 2 to improve recognition by the G48 antiserum, and by addition of the rhodopsin epitope at the C-terminus. Wild-type and modified hPTH1R were equally well expressed, as (Table I) The SDS-PAGE purified receptor band was electrotransferred to PVDF membrane and subjected to sequence analysis for 10 cycles, which yielded YALVDADDVM. Y23 at the amino-terminus is consistent with algorithms that predict removal of a 22 amino-acid signal peptide from the receptor's N-terminus. Signal peptide sequences are highly conserved among all cloned PTH1Rs, including opossum, rat, canine, murine, human, porcine and zebrafish, and thus tyrosine is the likely N-terminus in these mature receptors.
Purified and membrane-embedded hPTH1R have similar binding properties. Ligand
association to the high concentration of receptors in both membrane-embedded and purified hPTH1R, when still attached to the affinity gel was rapid; 1/2 maximal binding was achieved in less than 3 min at 21 o C; equilibrium binding was achieved within 10 min ( Fig 3A and B) . Ligand dissociation was measured after initially binding 125 I-PTH to the purified receptors for 1h at RT and then measuring residual binding at various times after addition of 10 -6 M PTH . Dissociation was rapid and biexponential; the half-time of the rapid component was approximately 3 min ( Fig 3C) . This compares favorably with dissociation of ligand bound to endogenous canine renal PTH1R and also to hPTH1R overexpressed in COS-7 cells after addition of GTPγS, 1-2 min (86) and 5 min (87), respectively. In the absence of added GTPγS, less than half of the PTH radioligand dissociated from endogenous receptors by 200 min (86) , which contrasts by guest on http://www.jbc.org/ Downloaded from strikingly with a half-time of only 6.5 min when radioligand is bound to exogenouslyexpressed receptors on COS-7 cells (87) .
Equilibrium binding to membrane-embedded receptors had a slightly lower affinity constant, Kd=11.9 +/-1.9 nM, specific binding-10.7+/-1.4 %, n=8) compared with binding to immobilized, purified hPTH1R (Kd=16.5 +/-1.3 nM, specific binding-18.6+/-4.7%, n=4) ( Fig 4A) , and was indistinguishable from the apparent affinity, Kd=17 nM, of ligand bound to canine renal membranes after treatment with GTPγS. In contrast, the apparent Kd of canine PTH1R in the absence of added GTPγS is 2-5 nM (86, 88) . The data are consistent with the notion that most of the extraordinarily large number of receptors expressed in COS-7 cells are not coupled to G proteins, and thus are in a low affinity state (87) . Because purified receptors are not associated with G proteins, they retain binding properties closely similar to those of membrane-embedded receptors in COS 7 cells.
The affinity of solubilized receptors also was measured after they had been eluted from the affinity gel and added to wells containing immobilized G48, which had been depleted of antibodies that recognize the epitope in the N-terminal ectodomain. Specific binding at equilibrium was 7.6+/-0.5% and the apparent Kd by Scatchard analysis was 69.5+/-16.9 nM (n=3) ( Fig 4B) . The higher affinity constant of these receptors may well reflect altered receptor conformation attendant to binding to the immobilized G48 antiserum. We cannot exclude, however, that receptors were slightly denatured upon elution from the 1D4 resin.
Purified PTH1R have functional N-terminal and juxtamembrane binding domains.
Binding of PTH and PTHrP to the PTH1R is consistent with a "two-site" model in which the C-terminal portion of the ligands interacts with the N-terminal ectodomain of the receptor and N-terminal portion of the ligands binds to juxtamembrane domains (13, 16, 17, (37) (38) (39) (40) 89) . We therefore sought to establish the integrity of these apparently distinct binding domains by assessing competition between 125 I-PTH (1-34) and four PTH or PTHrP fragments, PTH (1-34), PTHrP (5-36), Aib-PTH (1-21) and Aib-PTH (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) , whose binding properties with wild-type hPTH1R has been previously characterized on transfected intact COS-7 cells (89) . As with intact cells, PTH and PTHrP completely displaced the 125 I-PTH (1-34), whereas Aib-PTH (1-21) and Aib-PTH (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) maximally displaced 80% and 10% of the ligand, respectively. The IC 50 s of PTH and PTHrP were nearly identical, 17.0 +/-2.8 (n=5) and 20.8 +/-2.0 nM (n=5), respectively, whereas the IC 50 of Aib-PTH (1-21) was estimated to be ~50 nM (n=5) ( Fig   4C) . Thus, N-terminal and juxtamembrane binding determinants are both functional in the purified hPTH1R.
PTH treatment of purified hPTH1R reconstituted in phospholipid vesicles with G proteins stimulates incorporation of [ 35 S]GTPγS into Gs.
We first determined that 0.1% DM was sufficient to solubilize the phospholipids (data not shown). Purified hPTH1R Fig 5C) . The antagonist peptide, PTHrP (5-36) did not increase incorporation of [ 35 S] GTPγS into Gs (data not shown). We were unable to assess ligand binding to hPTH1R in phospholipid vesicles under the conditions tested, because non-specific binding was too high to permit interpretation of the data with confidence.
In summary, we have purified hPTH1R to apparent homogeneity, demonstrated that the signal peptide is removed, leaving Y23 as the N-terminus of the mature receptor. 
